ImmuCision developes innovative immunotherapy technologies to enhance cancer treatment

At Immucision Biotherapeutics, we focus on research and clinical development of innovative immune cell-based therapies for human cancer. We leverage our unique expertise in  human dendritic cell engineering technology to bring in solutions in solving the most challenging problems in cancer treatment.